n. an atypical antipsychotic agent that is thought to bind to the presynaptic D2 dopamine autoreceptor, and thereby inhibit the release of dopamine from the presynaptic terminal. This drug issued in the treatment of schizophrenia. The U.S. trade name: Ability.

ARIPIPRAZOLE: "The person was prescribed aripirazole in order to control his or her symptoms of schizophrenia. "
Cite this page: N., Pam M.S., "ARIPIPRAZOLE," in, April 7, 2013, (accessed December 4, 2020).